Lilly, PA

By Jacob Gronholt-Pedersen COPENHAGEN, Nov 4 (Reuters) - Novo Nordisk's Wegovy pill beat third-quarter sales forecasts on Wednesday, a test of whether...

Oct 29 (Reuters) - Eli Lilly shares surged to a record high on Thursday, as sales of blockbuster weight-loss injections helped the drugmaker beat quar...

By Patrick Wingrove Oct 29 (Reuters) - Eli Lilly raised its full-year revenue forecast and beat third-quarter earnings expectations on Thursday, prope...

Retatrutide, a weekly injection, mimics three hunger-regulating hormones.

Eli Lilly's experimental drug retatrutide showed greater reduction in A1C and double the average weight loss in a head-to-head clinical study against Ozempic.

Oct 27 (Reuters) - Eli Lilly said on Tuesday that Patrik Jonsson, executive vice president and president of its international business, will retire at...

By Jonathan Stempel Oct 26 (Reuters) - A US judge on Monday rejected Novo Nordisk's request to block Eli Lilly from continuing weight-loss drug advert...

Oct 19 (Reuters) - Hong Kong-listed Metis TechBio on Monday said it has entered a collaboration agreement with Eli Lilly worth up to $1.1 billion for ...

Oct 16 (Reuters) - The European Medicines Agency's committee on Friday recommended approval of Eli Lilly's weight-loss pill Foundayo, making it the se...